IP Library › Assignment 033161/0789
Patent Assignment
Reel/Frame 033161/0789

Assignment of Assignor's Interest

Recorded: 2014-06-09 Pages: 6
Assignor
THERAVANCE, INC.
Executed: 2014-06-01
Assignee
THERAVANCE BIOPHARMA R&D IP, LLC
901 GATEWAY BOULEVARD, SOUTH SAN FRANCISCO, CALIFORNIA, 94080
Covered Properties (4)
Aryl Aniline BETA2 Adrenergic Receptor Agonists
Patent: 6,670,376 →
Application: 10/292,835 →
Aryl Aniline BETA2 Adrenergic Receptor Agonists
Patent: 7,125,892 →
Application: 10/643,196 →
Publication: US 2004/0063755
Aryl Aniline BETA2 Adrenergic Receptor Agonists
Patent: 7,553,971 →
Application: 11/400,959 →
Publication: US 2006/0178410
Novel aryl aniline beta2 adrenergic receptor agonists
Application: 60/343,771 →
Related Assignments (5)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest May 2, 2002
From: MORAN, EDMUND J.; JACOBSEN, JOHN R.; AGGEN, JAMES
To: ADVANCED MEDICINE, INC.
Reel/Frame 012872/0848 →
Assignment of Assignor's Interest Feb 25, 2003
From: CHURCH, TIMOTHY J.
To: THERAVANCE, INC.
Reel/Frame 013446/0103 →
Assignment of Assignor's Interest Feb 25, 2003
From: MORAN, EDMUND J.; JACOBSEN, JOHN R.; LEADBETTER, MICHAEL R.; NODWELL, MATTHEW B.
To: THERAVANCE, INC.
Reel/Frame 013446/0243 →
Assignment of Assignor's Interest Feb 25, 2003
From: CHURCH, TIMOTHY J.
To: THERAVANCE, INC.
Reel/Frame 013810/0659 →
Assignment of Assignor's Interest Feb 25, 2003
From: MORAN, EDMUND J.; JACOBSEN, JOHN R.; LEADBETTER, MICHAEL R.; NODWELL, MATTHEW B.
To: THERAVANCE, INC.
Reel/Frame 013810/0675 →